V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody (Biotin)
377€ (200 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx272432
tested applications
WB, IHC, IF/ICC
Description
V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody (Biotin) is a Rabbit Polyclonal antibody conjugated to Biotin against V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Target: V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 0.5-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Biotin |
| Isotype | IgG |
| Purification | Purified by antigen-specific affinity chromatography. |
| Size 1 | 200 µl |
| Size 2 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-15 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Background | Antibody anti-VTCN1 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Descripción
Related Products
Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit
Ver Producto
VTCN1 antibody
Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.
Ver Producto